This shows that for some, this drug can present a powerful and potentially rapid way of reducing body weight in non diabetics struggling with obesity or overweight issues who might otherwise find it difficult to lose the required amount of pounds
Why? One of the biggest hurdles with GLP-1 therapy is managing cravings and controlling portions
Dulaglutide, a modified analog of human GLP-1 covalently linked to IgG4, possesses a notably extended half-life of about 90 h, thereby expanding its therapeutic applications
Common scenarios include achieving target weight loss goals, experiencing intolerable adverse effects such as persistent nausea or gastrointestinal disturbances, financial constraints related to medication costs, pregnancy planning or confirmation (tirzepatide should be discontinued when pregnancy is recognized), or development of contraindications
A very difficult job, because there really wasnt the support for it until the good results with semaglutide came along